Mortality | 7-day n=16 Follow-up 100% | 30-day n=48 Follow-up 100% | 90-day n=94 Follow-up 100% | |||
OR (95% CI) | P value | OR (95% CI) | P value | OR (95% CI) | P value | |
Acuity | ||||||
1 | 2.9 (1.0 to 8.8)* | 0.06 | 4.9 (1.3 to 19.3) | 0.02 | 2.7 (1.2 to 6.2) | 0.02 |
2 | 2.5 (0.7 to 8.6) | 0.2 | 1.3 (0.6 to 2.6) | 0.5 | ||
3 | Referent | 1.2 (0.3 to 4.2) | 0.8 | 0.8 (0.4 to 1.6) | 0.5 | |
4 | Referent | Referent | ||||
CFS≥5 | 10.7 (2.3 to 50.5) | 0.003 | 6.0 (3.0 to 12.3) | <0.001 | 6 (3.6 to 9.1) | <0.001 |
Age | 1.1 (1.0 to 1.1) | 0.1 | 1.04 (1.0 to 1.1) | 0.02 | 1.03 (1.0 to 1.1) | 0.05 |
Arrival by ambulance | 1.2 (0.3 to 4.8) | 0.8 | 1.5 (0.7 to 3.3) | 0.3 | 1.4 (0.9 to 2.4) | 0.2 |
Sex | 2.01 (0.77 to 5.22) | 0.2 | 1.6 (0.9 to 2.7) | 0.1 | 1.6 (1.1 to 2.4) | 0.01 |
*Acuity levels combined due to few outcomes for 7-day mortality.
CFS, Clinical Frailty Scale.